Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7860915 | 1.00 | GRM2 (0.55) | GRM2KCNH2 | |
| SCHEMBL10322993 | 0.90 | GRM2 (0.57) | GRM2KCNH2 | |
| SCHEMBL7859732 | 0.88 | GRM2 (0.57) | GRM2 | |
| SCHEMBL10321992 | 0.87 | GRM2 (0.59) | GRM2 | |
| SCHEMBL10322126 | 0.86 | GRM2 (0.57) | GRM2 | |
| SCHEMBL7860084 | 0.85 | GRM2 (0.56) | GRM2KCNH2 | |
| SCHEMBL10321900 | 0.85 | GRM2 (0.54) | GRM2KCNH2 | |
| SCHEMBL10321108 | 0.84 | GRM2 (0.60) | GRM2 | |
| SCHEMBL10321710 | 0.84 | GRM2 (0.55) | GRM2KCNH2 | |
| SCHEMBL10321189 | 0.83 | GRM2 (0.51) | GRM2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |